Phase 1a: A Randomized, 2-period Cross-over Study to Compare the Bioavailability of Gamma-Delta Tocotrienol (GDT) With That of Tocotrienol Rich Fraction (TRF) in Twelve Healthy Subjects
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Tocotrienols
- Indications Advanced breast cancer; Hypercholesterolaemia; Solid tumours
- Focus Pharmacokinetics
- 14 Sep 2016 Biomarkers information updated
- 17 Apr 2012 New trial record